MirNAS and their putative roles in the development and progression of Parkinson's disease

Garry Wong, Richard Nass

Research output: Contribution to journalReview article

9 Scopus citations


Small regulatory RNAs, such as miRNAs, are increasingly being recognized not only as regulators of developmental processes but contributors to pathological states. The number of miRNAs determined experimentally to be involved in Parkinson's disease (PD) development and progression is small and includes regulators of pathologic proteins, neurotrophic factors, and xenobiotic metabolizing enzymes. PD gene-association studies have also indicated miRNAs in the pathology. In this review, we present known miRNAs and their validated targets that contribute to PD development and progression. We also incorporate data mining methods to link additional miRNAs with non-experimentally validated targets and propose additional roles of miRNAs in neurodegenerative processes. Furthermore, we present the potential contribution of next-generation-sequencing approaches to elucidate mechanisms and etiology of PD through discovery of novel miRNAs and other non-coding RNA classes.

Original languageEnglish (US)
Article numberArticle 315
JournalFrontiers in Genetics
Issue numberJAN
StatePublished - 2013


  • Alpha-synuclein
  • Dopamine
  • Mir-7
  • Neurodegeneration

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'MirNAS and their putative roles in the development and progression of Parkinson's disease'. Together they form a unique fingerprint.

  • Cite this